High materiality7/10
Maze Therapeutics initiated with a Buy at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity initiates MAZE with a Buy; target $75; current price $27.53.
- Canaccord initiates MAZE with Buy; target $75 vs $27.53
Key facts
- 01
Target: $75
- 02
Posted price: $27.53
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.